Company: RDPTF
Filing Date: 2025-09-15
Form Type: 6-K
Source: 0001213900-25-087432
Chunk: 0

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-15
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of September 2025

Commission File Number: 001-41621

RADIOPHARM THERANOSTICS LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)</div>

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form 40-F ☐</div>

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

<div align='center'>Yes ☐ No ☒</div>

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

<div align='center'>RADIOPHARM THERANOSTICS LIMITED

EXPLANATORY NOTE</div>

Radiopharm Theranostics Limited (the “Company”) published one announcement (the “Public Notice”) to the Australian Securities Exchange on September 15, 2025 titled:

| - | “Pivalate (Brain Mets) key opinion leader webinar” |

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

<div align='center'>1

EXHIBITS</div>

| Exhibit 
 Number  |     | Description                                      |
| 99.1    |     | Pivalate (Brain Mets) key opinion leader webinar |

<div align='center'>2

SIGNATURE